4523.T
Eisai Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 4,811.00
+1.67%Year over year
Reported trailing growth
- Revenue
- +2.1%
- EBITDA
- —
- EBIT
- -25.0%
- EPS
- -26.4%
- Free cash flow
- +964.3%
- Operating cash flow
- +359.0%
Forward estimates
Based on analyst estimates
- Revenue
- -2.3%
- EBITDA
- —
- EPS
- -2.9%
Three-year CAGR
- Revenue
- +1.4%
- EBITDA
- +0.8%
- EBIT
- +0.4%
- Net income
- -1.1%
- EPS
- -0.7%
- Free cash flow
- -41.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026